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Thesis Advisor: Vidya Gopalakrishnan, Ph.D.

The RE1 Silencing Transcription Factor (REST) is a negative regulator of neuronal
differentiation. It is expressed ubiquitously in early embryos, but downregulated in neural
progenitors concomitant with onset of neuronal differentiation in these cells. REST has
been widely studied as a negative regulator of neuronal differentiation genes. Our recent
work identified a novel role for REST in control of cell proliferation. However, the
underlying molecular mechanism(s) are not known and is a focus of the current thesis
project. Here, we provide evidence that REST signaling controls the expression of the
cyclin-dependent kinase inhibitor, p16Ink4a, a negative regulator of the cell cycle and
passage through G1. We determined that REST expression in the proliferating granule
progenitors of the cerebellum and its lack of expression in the differentiated neurons is
reciprocally correlated with that of p16Ink4a. Decline in REST levels in differentiating
primary and neural stem cells immortalized with v-myc (NSC-M) granule progenitors in
vitro was also associated with upregulation of p16Ink4a expression. Conversely, constitutive
human REST transgene expression in NSC-M cells (NSC-MRs) blocked p16Ink4
upregulation, even under neuronal differentiation conditions. However, the lack of a
consensus REST DNA binding RE1 element in the regulatory regions of p16Ink4a locus
suggested an indirect regulation of p16Ink4a by REST. Based on work from other groups
that showed repression of p16Ink4a transcription by the polycomb protein Bmi-1, and its
negative regulation by microRNA-203 (miR-203) and our identification of a RE1 element
in the downstream regulatory region of miR-203, we asked if the p16Ink4a expression was

v

controlled by REST through a series of negative regulatory events involving miR-203 and
Bmi-1. We observed that Bmi1 -expression mirrored that of REST and inversely
correlated with that of miR-203 in the postnatal cerebellum and in vitro differentiated
granule and NSC-M progenitors. In contrast, forced REST transgene expression in NSCMR cells abrogated the decrease in Bmi-1 levels and elevation in miR-203 expression.
Significant REST binding to the miR-203 RE1 element was also observed in NSC-M cells,
indicating that REST had the potential to directly regulate miR-203 expression. In
conclusion, our studies suggest a role for REST in control of cell cycle transit in neural
progenitors through negative regulation of p16Ink4a. Further validation of these results in
REST knockout mice is needed, and is ongoing.
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Chapter 1
Introduction
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Control of Proliferation and Differentiation in the Cerebellum.
The cerebellum is the region of the brain that is important for coordinating
motion and balance, motor learning, and higher cognitive functions. The cerebellum
develops from the posterior neural tube (1, 2). Although it composes only about 10% of
total brain volume, it contains more than half of the neurons in the brain (1, 2). In
humans, the cellular organization of the cerebellum is in flux for approximately one year
after birth (1), making it highly vulnerable to developmental irregularities, such as
medulloblastoma (MB), a highly malignant pediatric brain tumor.
The cerebellum is derived from cells in the ventricular zone and the rhombic lip
(1, 2). The subventricular zone (SVZ) is compromised of the Purkinje cells of the
cerebellar cortex and the Bergman glia cells (1, 2). The rhombic lip gives rise to the
granular neural precursors, or cerebellar progenitor cells (CPCs) (Fig. 1A and 1B) (1, 2).
In mice, the Purkinje cells develop around embryonic day (E) 13, and, shortly thereafter,
migrate radially over the already formed deep cerebellar nuclei (Fig. 1B). There they
settle beneath the external granular layer (EGL), awaiting the inward migration of the
CPCs (1). At approximately E11, CPCs begin their first round of proliferation in the
rhombic lip and initiate their migration over the surface of the cerebellum to form the
outer EGL at approximately E27 (1). These cells display the proliferation markers Math1
and Nestin (Fig. 1A) (1, 4, 5). The CPCs in the outer EGL undergo their second round of
proliferation shortly after birth (1).
There are four major pathways that control CPC expansion, the Sonic hedgehog
(SHH) pathway, the Notch pathway, the Wingless (Wnt) pathway, and the Bone
Morphogenic Protein (Bmp) negative growth regulator pathway (6-9). SHH was the first
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key mitogen discovered to promote CPC neurogenesis (6) and its role in neurogenesis
has been extensively studied. For CPC proliferation to occur post-natally, the Purkinje
cells secrete SHH (1, 2, 10). SHH ligand binds to the Patched (PTCH) receptor found on
the membrane of CPCs in the outer EGL (7, 10) (Fig. 1C). In the absence of SHH,
PTCH1 binds to Smoothened (Smo), a G-protein coupled receptor necessary for SHHmediated signaling. Its association with PTCH prevents its translocation into the nucleus.
Thus, when SHH is present, PTCH1 dissociates from Smo, and the latter then signals the
CPCs in the EGL to expand and proliferate (7, 10).
Eventually, CPCs switch from a proliferation stage to a differentiating stage
through cell-intrinsic mechanisms. The SHH mitogenic pathway contains a negative
feedback loop that drives CPC cell cycle exit. In the presence of SHH, β-arrestin 1
(βArr1), a negative regulator of G-protein coupled receptors such as Smo, begins to
accumulate (11). Subsequently, βArr1 is phosphorylated at serine 412, causing a
translocation from the cytoplasm to the nucleus where it participates with CREB and
p300 to enhance expression of cyclin dependent kinase inhibitor p27Kip1 (11).
Accumulation of p27Kip1 ultimately drives CPC cell cycle exit, causing the CPCs to
begin migrating downward, forming post-mitotic neurons within the inner EGL (Fig.
1D). These post-mitotic neurons express early neuronal differentiation markers such as
p27kip1, NeuroD and neuron-specific class III β-tubulin (Tuj1) (1, 10, 12).

They

subsequently undergo terminal differentiation, extending axons that form synapses with
Purkinje cells as they continue to migrate through the molecular layer to form mature
neurons in the IGL (Fig. 1D) (10). The neurons in the IGL express neuronal
differentiation markers such as Synapsin1 and Synaptophysin.

3

In human cerebellar development, most cells in the IGL differentiate into
neurons after the first year concomitant with disappearance of the EGL. However, since
the cerebellum takes approximately a year to fully develop, it is highly susceptible to
developmental irregularities. Mutations in the genes of the SHH pathway have been
linked to excessive proliferation and account for about 30% of sporadic MB tumors (Fig.
1E) (1). A balance between positive and negative regulators of neurogenesis prevents
these irregularities from occurring. In 1995, two groups independently identified a gene
known as the Repressor element 1 (RE1) Silencing Transcription Factor (REST)/NeuronRestrictive Silencer Factor (NRSF), a negative regulator of neuronal phenotype (13, 14).
Subsequent studies identified a critical role for REST as a negative regulator of neuronal
genes in embryonic stem cells (ESC), neural stem cells (NSC)/progenitor cells, and nonneural cells (15-19).
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Figure 1: Cerebellar Development. A.) and B.): The rhombic lip gives rise to the
cerebellar progenitor cells (CPCs) that migrate toward the outer external granular
layer (EGL) while the ventricular zone gives rise to the Purkinje neurons and
Bergmann glia that settle beneath the EGL. C.) The Purkinje cells secrete a mitogen,
Sonic hedgehog, (SHH) that signals the CPCs in the EGL to expand and proliferate.
D.) Cessation of SHH signaling promotes CPC migration to the inner EGL to form
post-mitotic neurons. These cells then differentiate and continue to migrate through
the molecular layer and become terminally differentiated neurons in the internal
granular layer (IGL) (Fig. 1D). E.) Repressor element 1 (RE1) Silencing Transcription
Factor (REST) is a major regulator of cerebellum development (13, 14). (Adapted
from Dahmane and Altaba, 1999 and Wang and Zoghbi, 2001)
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REST is a Repressor of Neuronal Differentiation Genes
REST is a transcriptional repressor of neuronal differentiation genes (14). It is
found in human, mouse, chick, fugu, and many other organisms (19, 20). In mice, REST
expression is highest in non-neural cells of the developing embryo, where neuronal
genes must be silenced (17). Studies of REST null mice showed they have malformed
brains, exhibit ectopic expression of some neuronal differentiation genes and die early in
development at E11.5. (19). REST is also expressed in ESCs, NSCs, and non-neural cells,
but is downregulated in most neurons, consistent with its role as a negative regulator of
neuronal genes (13, 14, 19, 21, 37). This suggests REST may be important for brain
development in vertebrates.
REST is a 116 kDa zinc finger protein that contains a DNA binding domain
localized within a central cluster of eight zinc finger domains (Fig. 2A) (13, 15). REST
has a proline-rich region and a lysine-rich region that contains one of its nuclear
localization signals (NLS) (Fig. 2A) (13, 15). The other NLS is found on zinc finger 5
(13, 15). It also has two separate repressor domains located at the amino-(N) and
carboxy-(C) terminus (Fig. 2A) (13, 15). The N-terminal repressor domain interacts with
mSin3A while the C-terminal repressor domain interacts with CoREST (15, 22). Both
repressor domains recruit histone deacetylase (HDACs) silencing complexes to remodel
chromatin and repress gene expression (15, 22). In addition, REST contains two degron
sequences in the c-terminus (23, 24).
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A. REST Structure

B. RE1 Consensus Sequence

Figure 2: Structure of REST protein and its DNA binding Consensus Sequence.
A.) REST contains a DNA binding domain (DBD) localized within a cluster of eight
zinc finger domains. It has two nuclear localization signals (NLS), one on zinc finger
5 and the other in the Lys-rich sequence. It also contains two degron sequences in the
c termini and two separate repressor domains located at the amino-(N) (RD1) and
carboxy-(C) (RD2) termini of the protein. B.) REST binds to the RE1 consensus
sequence in the regulatory regions of its target genes. (Adapted from Chong et al.,
1995; Schoenherr et al., 1995; and Ballas et al., 2005)
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A number of studies have determined that REST binds to a 21-23 base pair
consensus DNA binding motif called the RE1 element in the regulatory region of its
target genes (Fig. 2B) (13, 14, 20, 21). These sites may be proximal or distal to the
transcription start site, or they may be located within introns (20). Recent genome-wide
analysis of potential RE1 sites revealed that there are over 1,892 human, 1894 mouse,
and 554 Fugu RE1 sites identified as potential target genes of REST (20). Many of these
genes are expressed within the nervous system and known to encode essential neuronal
traits such as ion channels, synaptic vesicle proteins, vesicular trafficking/fusion, and
neurotransmitter receptors (20, 25). Due to the number of RE1 sites, REST target genes
are divided into three classes. Target genes that are directly upregulated in the absence of
REST are known as class I genes (17, 19). Class II REST target genes require both the
absence of REST function as well as the presence of other positive activators (17, 19).
There is a new emerging class of REST target genes, Class III, that require both the
absence of REST as well as relief from other repressive activities, such as CoREST (21).
Interestingly, the genome-wide sequence also revealed that some shortnoncoding RNA, known as microRNAs (miRs), have RE1 binding sites. MiRs regulate
gene expression at the post-transcriptional level by binding to the 3’ untranslated regions
(3’UTR) of their target messenger RNA (mRNAs) and silence gene expression by either
degrading the mRNA, or reducing translation efficiency during tissue development (2630). Specifically, REST regulates expression of many miRs known to promote neuronal
differentiation such as miR-124a, miR-9, and miR-132 (22). One of the first miRs shown
to be regulated by REST was miR-124a, which is known to repress non-neuronal
transcripts. Thus, in non-neural cells, REST binds to miR-124a to repress its expression
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and promote non-neuronal transcripts (31, 32). However, in neuronal cells, REST is no
longer repressing miR-124a, causing rapid degradation of non-neuronal transcripts
allowing a neuronal phenotype (31). Additionally, in mouse ESCs, REST represses
expression of miR-21, a negative regulator of some self-renewal genes such as Sox2, cMyc, Nanog, and Oct4 (33).
To further assess the importance of REST-mediated repression on neurogenesis,
previous studies constructed a recombinant transcription factor, REST-VP16, which
binds to the same DNA binding site but instead of the two repressor domains, it contains
an activation domain of herpes simplex virus protein VP16 (34). This group found that
REST-VP16 can compete with endogenous REST for binding and transcriptionally
activate REST target genes (35, 36). Additionally, in NSCs, the direct activation of
REST target genes by REST-VP16 was sufficient to induce differentiation of NSCs into
functionally active neurons and convert the cells into a mature neuronal phenotype (35).
Moreover, REST can function as an activator of a subset of its own neuronal
target genes in adult neurogenesis. When REST was bound to a non-coding double
stranded RNA (dsRNA) with similar homology to the RE1 site, REST functioned as an
activator of its target neuronal differentiation genes in NSCs leading to neuronal
differentiation (37).
REST itself is regulated at the post-translational level. In non-neural cells, βTransducin repeat-containing protein (β-TRCP), an E3 ligase, promotes degronmediated proteosomal degradation of REST during the G2 phase of the cell cycle (24).
Similarly, when ESCs progress on their way to lineage restricted neural progenitors,
REST protein is degraded by β-TRCP-mediated ubiquitylation and the proteosomal
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degradation complex (23). At this point, although protein levels are being lowered by
degradation, the REST-corepressor complex still occupies and represses its target genes.
This repression in NSCs is weak in comparison to the repression in non-neural cells and
ESCs, where neuronal genes must be permanently silenced (17). REST transcript levels
do not decrease until the NSCs exit the cell cycle and differentiate into neurons. REST
transcription was shown to be negatively regulated by the binding of the unliganded
retinoic acid receptor element (RARE) found on the REST promoter (15). The
downregulation of REST expression concomitant with neuronal lineage specification is
associated with derepression of REST target genes (15, 21, 22).
REST is an Oncogene in Neural Tumors
Medulloblastoma, a malignant pediatric brain tumor, is characterized by poor
neuronal differentiation and hyper-proliferation (3, 35, 38). Previous studies have shown
elevated REST expression in human MB samples compared to normal age-matched
cerebella (35, 38). These results suggest a defect in pathways controlling the
downregulation of REST expression (21, 38). Countering REST expression in the human
MB cell line, DAOY, abrogated the tumorigenic potential of these cells in mouse
orthotopic models (38). Conversely, v-myc immortalized mouse cerebellar progenitor
cells (NSC-Ms) engineered to constitutively express REST under a doxycycline
promoter (NSC-MRs) failed to differentiate and maintained a proliferative state as
shown by an immunocytochemical assay for BrdU incorporation (Fig. 3) (3).
Additionally, ectopic REST expression in murine progenitors promoted formation of
cerebellar tumors in murine cerebellum, implicating REST in MB formation (3) and
Immunofluorescence Analysis (IFA) showed NSC-MR cells lacked differentiation
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markers, indicating that they cannot become terminal neurons and offered a proliferative
advantage. (3). More recently, we have shown that REST expression maintains
proliferation in MB tumor cells at least in part through regulation of expression of
p27Kip1 (73).
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Figure 3: An immunocytochemical assay for BrdU incorporation in NSC-M and
NSC-MR cells. Cells were plated under either proliferation or differentiation
condition, BrdU was added to the media and the cells were washed, fixed, and stained
with anti-BrdU for immunocytochemical analysis. NSC-M cells incorporate BrdU at
a much lower rate under differentiation conditions compared to proliferation
conditions. In contrast, NSC-MR cells expressing the human REST transgene (NSCMRs -Dox) incorporate BrdU at high rates even when cultured under differentiation
conditions (3).
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REST is a Tumor Suppressor in Non-Neural Tumors
A variety of human tumors arising from epithelial cells of tissues including
breast, ovarian, colorectal, and lung cancer, show abnormal activation of neuron-specific
genes. This suggested a defect in the regulators of neuronal genes. REST is normally
widely expressed throughout non-neural tissues to silence neuronal genes. Therefore,
when it is deleted or mutated, some of its neuronal genes are aberrantly expressed. REST
was identified as a frequently deleted gene in colorectal cancer (39). In addition, using
an RNA interference mechanism, blocking REST function in the mammary epithelial
cells was shown to cause a transformation phenotype leading to a transformed breast cell
(39). Thus, the inhibition of REST function seems to be a common event that occurs in
diverse tissues during normal physiological responses, as well as disease.
REST Expressing Cells offer a Proliferation Advantage.
Previous studies showed that NSC-MR cells offer a proliferation advantage over
NSC-M cells as shown by an immunocytochemical assay for BrdU incorporation (3)
(Fig. 3). We have shown that REST knockdown in NSC-Ms and human MB cell lines
(DAOY and D283), inhibits proliferation as shown by a reduced cell number (Fig. 4)
(73). To verify if this was indeed through a proliferation mechanism, we stained for the
proliferation marker Ki-67 and found a decrease in Ki-67 positive cells (Fig. 4) (73).
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Figure 4: REST knockdown by transient transfection in NSC-M cells and two
MB cell lines (DAOY and D283). Cells were transiently transfected with pooled
REST specific siRNA or control scrambled (scr) siRNA using DharmaFect transfection
reagent. REST knockdown promoted a decline in total cell number (left panel) and a
decline in the number of Ki-67 positive cells (right panel). (73).

Together, these results implicate REST in controlling cell proliferation. REST is
expressed in the G1 phase of the cell cycle and is targeted for degradation by β-TRCP
during the G2 phase of the cell cycle (24). Transit through the cell cycle is governed by
the activity of a family of proteins called the cyclin dependent kinases (CDKs) (Fig. 5).
These CDKs interact with regulatory subunits known as cyclins and form heterodimers
to phosphorylate retinoblastoma (RB) and allow progression through the cell cycle (Fig.
5) (40). The activity of these CDK/Cyclin interactions is controlled by the CDKIs, which
include the kip family (p21Cip1 and p27Kip1) and the Inhibitor of Kinase 4 family (Ink4)
(p15Ink4b, p16Ink4a, p18Ink4c) (Fig. 5) (40). CDKIs are known inhibitors of cell
proliferation. Overall, these results suggest that REST may control cell proliferation by
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negatively regulating the expression of one or more CDKIs. Our lab recently
demonstrated a novel role for REST in the regulation of the cell cycle and proliferation
through negative regulation of p27Kip1 (73). However, the pathways responsible for the
other CDKIs are still relatively unknown. Interestingly, p16Ink4a expression is relatively
low in progenitor cells and premature expression of p16Ink4a contributes to the reduced
self-renewal of neural stem cells in culture (41-43). Furthermore, p16Ink4a expression
also coincided with a significant decline in proliferation.

Figure 5: Progression through the cell cycle is governed by the CDK-cyclin
interactions. Transit through the cell cycle is governed by CDK-cyclin interactions.
Together, they form heterodimers to phosphorylate RB and allow progression through
the cell cycle. These CDK/Cyclin interactions are negatively regulated by the CDKIs
(40).
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Hypothesis
The overall goal of my project is to elucidate the molecular mechanism(s) underlying
REST-mediated control of cell proliferation during neuronal differentiation.
To summarize, we know that:
1.) REST overexpressing NSC-MR cells offer a proliferation advantage compared to
NSC-M cells as shown by an immunocytochemical assay for BrdU incorporation
(3).
2.) REST knockdown in NSC-M and human MB cell lines promotes a decrease in
cell number and corresponding decrease in the proliferation marker Ki-67 (73).
3.) REST is expressed in the G1 phase of the cell cycle and is targeted for
proteosomal degradation by β-TRCP in G2 phase of the cell cycle (24).
4.) Progression through the cell cycle is governed by CDK/cyclin activity. The
CDKS are regulated by CDKIs (40).

The research presented in this dissertation was performed to test the hypothesis
that REST promotion of proliferation may in part be through negatively regulation of
expression of CDKIs. Therefore, I will study the relationship between REST and the
Ink4a/ARF family member, p16Ink4a and demonstrate as follows:
1.) REST and p16Ink4a correlation
i. In vivo cerebellum
ii. In vitro in NSC-M and NSC-MR cell lines
2.) Mechanism by which REST regulates p16Ink4a
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Chapter 2
REST and p16Ink4a expression are reciprocally correlated during neural
development
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Rationale

Previous work showed that NSC-MR cells constitutively expressing a human
REST transgene (NSC-MR) failed to differentiate and continued to proliferate as
determined by BrdU labeling assays (3). We showed that REST knockdown in NSC-M
cells promoted a decrease in cell numbers and a corresponding decrease in the
proliferation marker Ki-67 (73). REST is expressed in the G1 phase of the cell cycle and
is targeted for degradation by β-TRCP during the G2 phase of the cell cycle (24).
Progression through the cell cycle is governed by cyclin/CDK activity, which is
regulated by the CDKIs (40). CDKIs are known to be negative regulators of cell
proliferation (40). Based on these findings we postulate that REST-mediated control of
cell proliferation may in part involve negative regulation of CDKI expression or activity.
Premature expression of p16Ink4a was shown to cause significant decline in proliferation
and reduced self-renewal of neural stem cells in culture (41-43).
In this section, we investigated the relationship between REST and the CDKI,
p16Ink4a, during neurogenesis in differentiating progenitors in vitro and in differentiating
CPCs of the postnatal cerebellum. We show that REST and p16Ink4a levels are
reciprocally correlated in the developing mouse cerebellum at postnatal day 7 (P7) and
P12 by immunofluorescence analysis (IFA). REST and p16Ink4a expression was also
studied by reverse transcriptase polymerase chain reaction (qRT-PCR), Western Blotting
(WB) and IFA during neuronal differentiation of progenitors in vitro. We observed that
REST mRNA and protein levels in NSC-M cells were expressed in progenitors whereas
p16Ink4a was not. Conversely, REST was downregulated in neurons whereas p16Ink4a was
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detected. Furthermore, constitutive REST expression in NSC-MR cells blocked
upregulation of p16Ink4a mRNA and protein levels, even when cultured under
differentiation conditions. Together, our data suggests a reciprocal relationship between
REST and p16Ink 4a.
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Results

REST and p16Ink4a are reciprocally expressed in the developing post-natal
cerebellum of mice.
In order to determine if REST reciprocally correlated with p16Ink4a in vivo, REST
and p16Ink4a protein was analyzed in the developing cerebellum of P7 and P12 mice.
C57BL6 mice were mated and the brains of the resulting pups were harvested using
IACUC approved protocols various days after birth and analyzed by IFA assays using
commercially available anti-REST (red) or anti-p16Ink4a (green) antibodies. In P7 mice,
REST is mostly in the proliferating cells of the EGL where cells are undergoing
maximal proliferation while p16Ink4a is in the post-mitotic and terminally differentiated
neurons of the ML and IGL (Fig. 6). In P12 mice, REST levels are declining as the EGL
is diminished to a few layers of progenitor cells (Fig. 6). Most of the cells are now
expressing p16Ink4a and are post-mitotic and terminally differentiated neurons (Fig. 6).
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Figure 6: REST and p16Ink4a are reciprocally expressed in the developing postnatal cerebellum of mice. C57BL6 wild-type mice were mated and the brains of
the resulting pups were harvested using IACUC approved protocols. REST and
p16Ink4a protein in normal P7 and P12 mouse cerebellum was measured by
immunofluorescence assay using commercially available anti-REST (red) and antip16Ink4a (green) antibodies. Nuclei were stained with Hoechst dye and representative
images were captured using a 10X lens (top panel) or 40X oil immersion lens
(middle and bottom panel) on a Nikon fluorescence microscope. Images were
analyzed with Metamorph software. Experiments were performed in duplicate.
EGL-External Granule Layer; IGL- Internal Granule Layer.
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REST expressing cells blocked p16Ink4a upregulation.
To examine the relationship between REST and p16Ink4a during neuronal
differentiation of neural progenitors in vitro, NSC-M cells were cultured under
proliferation or differentiation conditions. Total RNA was collected and mRNA levels
were quantified by qRT-PCR analyses. Relative REST and p16Ink4a mRNA levels were
determined following normalization to 18S mRNA levels. Downregulation of REST gene
expression during neuronal differentiation significantly correlated with upregulation of
p16Ink4a gene expression (Fig. 7). The terminal differentiation marker Synapsin1 (Syn1)
was used as a positive control since it is an established REST target gene.
Conversely, NSC-MR cells cultured under these conditions maintained REST
expression and failed to upregulate p16Ink4a mRNA levels, even when cultured under
neuronal differentiation conditions (Fig. 7). Together these findings suggest that
maintenance of REST expression and a failure to upregulate p16Ink4a expression may
contribute to uncontrolled proliferation of NSC-MR cells.
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D.

E.

Figure 7: Maintenance of REST expression blocks p16Ink4a upregulation. NSC-M
(A, B, and C) and NSC-MR (D, and E) cells were grown under proliferation or
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed
by SYBR Green qRT-PCR to measure changes in gene expression of REST, p16Ink4a,
and Synapsin1 (Syn1). Experiments were done in triplicate, and error bars are
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01).
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Lowered p16Ink4a protein levels in Neural Progenitors with Constitutive REST
expression
To further validate the reciprocal relationship between REST and p16Ink4a during
neuronal differentiation of neural progenitors, we analyzed protein levels by WB. NSCM and NSC-MR cells were cultured under proliferation or differentiation conditions and
whole cell extracts were analyzed by WB and probed with commercially available antiREST or anti-p16Ink4a antibodies (Fig. 8A). Actin was used as a loading control. In NSCM cells, REST levels decline upon neuronal differentiation while p16Ink4a levels are
upregulated (Fig. 8A). In contrast, REST levels do not change in NSC-MR cells cultured
under differentiation conditions and these cells failed to upregulate p16Ink4a levels (Fig.
8A).
REST and p16Ink4a protein levels and sub-cellular localization were also studied
by IFA. NSC-M and NSC-MR cells were cultured in CC2 chamber slides under either
proliferation or differentiation conditions, fixed and stained with anti-REST (red) or
anti-p16Ink4a antibodies (green). 4’6-diamidino-2-phenylindole (DAPI) (blue) was used
to stain the nuclei. In NSC-M cells, REST was detected in both the nucleus and
cytoplasm of progenitor cells but was only detected in the cytoplasm of differentiated
neurons (Fig. 8B). In contrast, p16Ink4a was not expressed in progenitor cells and was
only expressed in the nucleus of differentiated neurons (Fig. 8B). Thus, downregulation
of REST protein levels during neuronal differentiation in NSC-M cells correlated with
upregulation of p16Ink4a protein levels (Fig. 8B). Conversely, NSC-MR cells maintained
REST levels and blocked upregulation of p16Ink4a protein levels, even when cultured
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under neuronal differentiation conditions (Fig. 8B), thereby confirming our findings in
Fig. 7 and Fig. 8A.
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Figure 8: Maintenance of REST levels blocks p16Ink4a upregulation. NSC-M and
NSC-MR cells were cultured under proliferation or differentiation conditions. A.)
Whole cell extracts were analyzed by Western blotting to measure changes in REST
and p16Ink4a protein levels. Actin was used as a loading control. Experiments were
done in triplicate. Actin was used as a loading control. Experiments were done in
triplicate. B.) Cells were processed by IFA to detect changes in protein levels and
sub-cellular localization of REST and p16Ink4a in NSC-M and NSC-MR cells. Cells
were stained using commercially available anti-REST and anti-p16Ink4a antibodies.
Nuclei were stained with DAPI. These representative images were captured using a
Nikon fluorescence microscope and analyzed with Metamorph software.
Experiments were done in duplicate.
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Summary

In this section, we investigated the relationship between REST and p16Ink4a
transcript and protein in mouse brain sections and in differentiating neural progenitors in
vitro. Tissue sections were obtained and analyzed in the developing cerebellum of P7
and P12 mice for REST and p16Ink4a. We found REST and p16Ink4a expression in the
proliferating cells of the EGL and post-mitotic/terminally differentiated neurons of the
IGL respectively. We also cultured NSC-M cells under proliferation or differentiation
conditions and demonstrated a decline in REST expression and increase in p16Ink4a
expression during neurogenesis of NSC-M cells by qRT-PCR, WB, and IFA. Conversely,
constitutive REST expression in NSC-MR cells blocked upregulation of p16Ink4a, even
when cultured under differentiation conditions. These findings suggested a reciprocal
relationship between REST and p16Ink4a. The mechanism by which REST may regulate
p16Ink4a will be discussed in the next section.
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Chapter 3
REST represses miR-203, a negative regulator of Bmi-1, to prevent p16Ink4a
expression and allow cell proliferation.
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Rationale

In the previous section, we demonstrated a reciprocal relationship between REST
and p16Ink4a in neural progenitors in vivo and in vitro. Since REST is a transcriptional
repressor, we first asked if REST directly controlled p16Ink4a expression. We conducted a
search of the upstream and downstream regulatory regions of p16Ink4a gene for consensus
RE1 binding sites. However, the search did not reveal REST binding sites in the p16Ink4a
regulatory regions, suggesting that the effect of REST on p16Ink4a may be indirect.
Several lines of evidence have implicated the polycomb gene, B- lymphoma Moloney
leukemia virus insertion region (Bmi-1), as a negative regulator of p16Ink4a gene
expression (41-45). Bmi-1 is essential for cerebellar development and is important for
regulation of CPC proliferation (42, 43, 46, 47). Bmi-1 null mice exhibit a precocious
increase in p16Ink4a expression that contributed to the reduced self-renewal of neural
stem cells in culture (43). It is a downstream target of the Shh pathway and aberrantly
high levels of Bmi-1 are found in many cancers, including medulloblastomas (46). Other
studies have shown that Bmi-1 is regulated by short non-coding regulatory RNA called
microRNAs (miRs) such as miR-15a, miR-16 and miR-203 (48, 49). Importantly, REST
controls the expression of miRs, specifically miR-9, miR-124 and miR-132 (32, 50, 51).
In this section, we investigated the hypothesis that REST mediated control of
p16Ink4a expression is through repression of miRs known to regulate Bmi-1 expression,
as outlined in Fig. 9. We examined this hypothesis during neurogenesis in differentiating
progenitors in vitro and in differentiating CPCs of the postnatal cerebellum. Additionally,
we first examined in NSC-M and NSC-MR cells the expression of a panel of miRs
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known to regulate Bmi-1 by TaqMan MicroRNA assay followed by qRT-PCR validation
(in collaboration with Dr. George Calin’s Lab). We then examined REST and Bmi-1
protein in vivo in the developing mouse cerebellum at P7 and P12 by IFA. We did a
chromatin immunoprecipitation (ChIP) experiment to show REST binding to the RE1
element in the downstream regulatory region of miR-203 in NSC-M and NSC-MR cells.
In our working model, we suggest that REST-mediated repression of miR-203 maintains
Bmi-1 expression and blocks p16Ink4a expression (Fig. 9).

Figure 9. REST-mediated control of cell proliferation- Working Model. REST
contributes to increased cell proliferation by repressing the expression of miR-203,
which negatively regulates Bmi-1. Therefore, Bmi-1 can inactivate p16Ink4a, increasing
cell proliferation and allowing progression through the cell cycle.
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Results

REST-dependent Changes in miR-203 expression.
We first asked whether REST dependent negative control of p16Ink4a was
mediated by a miR and Bmi-1. To assess this, NSC-M and NSC-MR cells were cultured
under proliferation and differentiation conditions. The expression of a panel of miRs
known to control Bmi-1 were examined by TaqMan MicroRNA assay followed by qRTPCR analyses. Gene expression was determined following normalization to U6 small
nuclear RNA (RNU6B) mRNA levels. Of these, miR-203 and miR-183 showed a RESTdependent downregulation of expression (Fig. 10A). The expression of the other
microRNAs failed to fluctuate in a REST dependent manner. Of these two miRs, only
miR-203 had a RE1 site and therefore had the potential to be bound by REST. As
highlighted in Fig. 10B, miR-203 expression was significantly downregulated in REST
overexpressing NSC-MR cells relative to NSC-M cells.
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Figure 10: MiR-203 and miR-183 fluctuate in a REST dependent manner. NSCM and NSC-MR cells were grown under proliferation conditions. Total RNA was
prepared and miR expression was quantified by TaqMan MicroRNA assay followed
by qRT-PCR analyses to measure changes in miR expression. A.) MiR expression of
a panel of miRs known to regulate Bmi-1. B.) Mir-203 expression is significantly
downregulated in NSC-MR cells relative to NSC-M cells. Experiments were done in
triplicate, and error bars are indicated. Statistical analysis was done using Statistica
6.0 (*p<0.05, **p<0.01).
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Constitutive REST expression blocked miR-203 upregulation and maintained Bmi1 expression in differentiated neural progenitors.
To better understand the relationship between REST, miR-203, and Bmi-1
expression we cultured NSC-M cells under either proliferation or differentiation
conditions. Total RNA was collected, converted to cDNA and 18s, Bmi-1, Syn1, and
REST gene expression quantified by SYBR Green qRT-PCR. For miR-203
measurements, total RNA was collected and mRNA levels were assessed by TaqMan
MicroRNA assay followed by qRT-PCR analyses. REST gene expression (normalized to
18S expression) and miR-203 (normalized to RNU6B expression) mRNA levels were
found to be reciprocally correlated in differentiating NSC-M cells (Fig. 11). This shows
downregulation of REST gene expression during neuronal differentiation caused a
significant upregulation of miR-203 gene expression (Fig. 11). The terminal
differentiation marker Synapsin (Syn1), a known REST target gene was upregulated
under these conditions and was used as positive control. Importantly, Bmi-1 mRNA
levels were downregulated concomitant with a decline in REST mRNA levels during
neuronal differentiation (Fig. 11).
In contrast, maintenance of REST expression in NSC-MR cells blocked the
upregulation of miR-203 mRNA levels, even when cultured under differentiation
conditions (Fig. 12). This correlated with maintenance of Bmi-1 mRNA levels in these
cells (Fig. 12).
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Figure 11: REST gene expression and miR-203 mRNA levels were found to be
reciprocally correlated in differentiating NSC-M cells. NSC-M cells were grown
under proliferation or differentiation conditions. A.) Total RNA was prepared,
converted to cDNA and analyzed by SYBR Green qRT-PCR to measure changes in
gene expression of REST and Bmi-1. B.) Total RNA was prepared, and mRNA levels
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure
changes in gene expression of miR-203. Experiments were done in triplicate, and error
bars are indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05,
**p<0.01). C.) Total RNA was prepared, converted to cDNA and analyzed by SYBR
Green qRT-PCR to measure changes in gene expression of Synapsin1 (Syn1).
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Figure 12: Maintenance of REST expression blocks miR-203 upregulation and
maintains Bmi-1 expression. NSC-MR cells were grown under proliferation or
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed
by SYBR Green qRT-PCR to measure changes in gene expression of REST, Bmi-1,
and Synapsin1 (Syn1). For miR-203, total RNA was prepared, and mRNA levels
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure
changes in gene expression. Experiments were done in triplicate, and error bars are
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01).
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Constitutive REST expression maintains Bmi-1 levels.
REST and Bmi-1 sub-cellular localization was also studied by IFA analyses.
NSC-M and NSC-MR cells were cultured in CC2 chamber slides under either
proliferation or differentiation conditions, fixed and stained with anti-REST (red) or
anti-Bmi-1 (green) antibodies. DAPI (blue) was used to stain the nuclei. In NSC-M cells,
REST was detected in both the nucleus and cytoplasm of progenitor NSC-M cells but
was only detected in the cytoplasm of differentiated neurons (Fig. 13). Bmi-1 was found
predominantly in the nucleus of the proliferating NSC-M cells and was not detected in
NSC-M differentiated cells (Fig. 13). Thus, downregulation of REST protein levels
during neuronal differentiation in NSC-M cells coincided with downregulation of Bmi-1
protein levels (Fig. 13). Conversely, NSC-MR cells failed to differentiate and instead
maintained REST and Bmi-1 protein levels (Fig. 13). REST was detected in the nucleus
and cytoplasm of NSC-MR cells under both proliferation and differentiation conditions.
Bmi-1 was predominantly found in the nucleus of NSC-MR cells, even when cultured
under neuronal differentiation conditions. These findings further confirmed our findings
in Figs. 11, and 12.
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Figure 13: Constitutive REST expression maintains Bmi-1 levels. NSC-M and
NSC-MR cells were cultured under proliferation or differentiation conditions. Cells
were processed by IFA to detect changes in protein levels and sub-cellular localization
of REST and Bmi-1 in NSC-M and NSC-MR cells. Cells were stained using
commercially available anti-REST and anti-Bmi-1 antibodies. Nuclei were stained
with DAPI. These images were captured using a Nikon microscope and analyzed with
Metamorph software. Experiments were done in duplicate.
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REST and Bmi-1 are expressed in the progenitor cells of the mouse cerebellum.
To determine if REST and Bmi-1 were concomitantly expressed in the
proliferating cells of the EGL in vivo, REST and Bmi-1 protein levels were analyzed in
the developing cerebellum of P7 and P12 mice. C57BL6 mice were mated and the brains
of the resulting pups were harvested using IACUC approved protocols various days after
birth and analyzed by IFA assays using commercially available anti-REST (red) or antiBmi-1 (green) antibodies. In P7 mice, REST and Bmi-1 are detected in the proliferating
cells of the EGL but their levels are substantially reduced upon migration and they are
barely detected in the IGL (Fig. 14). In P12 mice, the EGL is diminished to a few layers
of progenitor cells and most cells in the cerebellum are now migrating post-mitotic and
terminally differentiated neurons. REST and Bmi-1 are barely detected in any of the
layers in P12 mice (Fig. 14).
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Figure 14: REST and Bmi-1 are expressed in the proliferating cells of the EGL.
REST and Bmi-1 are concomitantly expressed in the EGL of the developing post-natal
cerebellum of mice. C57BL6 mice were mated and the brains of the resulting pups
were harvested using IACUC approved protocols various days after birth. REST and
Bmi-1 protein in normal P7 and P12 mouse cerebellum was measured by
immunofluorescence assay using commercially available anti-REST (red) and antiBmi-1 (green) antibodies. Nuclei were stained with Hoechst dye and representative
images were captured using an Oil Immersion 40X lens on a Nikon fluorescence
microscope. Images were analyzed with Metamorph software. Experiments were
performed in duplicate. EGL- External Granule Layer, IGL-Internal Granule Layer.
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REST binds to miR-203 regulatory regions in NSC-M and NSC-MR cells.
To determine if miR-203 was a direct target of REST, we performed chromatin
immunoprecipitation (ChIP) assays on proliferating NSC-MRs and NSC-M cells, and
differentiating NSC-Ms. Cross-linked nuclear extracts were immunoprecipitated using
rabbit anti-REST antibodies or control rabbit immunoglobulin (IgG). Samples were
analyzed by qPCR using primers specific to mouse miR-203 and the sample values
(REST) minus the control values (IgG) were used to determine relative levels of REST
binding. We observed that REST bound to the regulatory region of miR-203 in NSC-M
and NSC-MR cells. Additionally, REST showed a significantly higher binding to the
miR-203 regulatory region relative to IgG controls in proliferating NSC-MR cells
compared to NSC-M cells plated under the same conditions (Fig. 15). Furthermore,
REST binding to miR-203 was significantly higher in proliferating NSC-M cells
compared to differentiated cells (Fig. 15). Together, these data suggests that miR-203
may be a direct REST target.
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Figure 15: REST binds to the miR-203 regulatory region in NSC-M and NSCMR cells. Chromatin Immunoprecipitation (ChIP) assays were performed as follows:
Cross-linked nuclear extracts prepared from proliferating NSC-MRs and NSC-M
cells, and differentiating NSC-Ms were immunoprecipitated using rabbit anti-REST
antibodies or control rabbit immunoglobulin (IgG). Samples were analyzed by qPCR
using primers specific to mouse miR-203 and the sample values (REST) minus the
control values (IgG) were used to determine relative levels of REST binding.
Experiments were done in triplicate, and error bars are indicated. Statistical analysis
was done using Statistica 6.0 (*p<0.05, **p<0.01).

45

Summary

In this section, we investigated the mechanism by which REST regulates p16Ink4a
expression. We observed miR-203 expression was lower in NSC-MR cells relative to
NSC-M cells as detected by Taqman MicroRNA assay followed by qRT-PCR analyses.
Additionally, ChIP analyses revealed REST binding to the RE1 element in the
downstream regulatory region of miR-203. Onset of neuronal differentiation in NSC-M
cells was accompanied by a decrease in REST and Bmi-1 expression and an increase in
miR-203 expression. Maintenance of REST expression in NSC-MR cells blocked the
differentiated associated decline in Bmi-1 levels and increased in miR-203, respectively.
In vivo, IFA analyses showed REST and Bmi-1 protein at high levels in the EGL of the
developing cerebella with their levels being substantially reduced upon migration to the
ML and IGL.
Our findings suggested that REST may contribute to increased cell proliferation
by repressing the expression of miR-203, a negative regulator of Bmi-1. Maintenance of
Bmi-1 expression prevented p16Ink4a transcription.
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Chapter 4
Discussion
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REST expression promotes cell proliferation in neural progenitor cells
REST is a negative regulator of neuronal phenotype and key regulator of brain
development in vertebrates (13, 14, 19). It is a transcriptional repressor of neuronal
differentiation genes. REST is expressed in ESCs, NSCs, and non-neural cells, but is
downregulated in most neurons, consistent with its role as a negative regulator of
neuronal gene expression (13, 14, 19, 21). In ESCs and NSCs, REST prevents the
premature expression of terminal neuronal differentiation genes by binding to the RE1
element in the regulatory regions of its target genes (13, 14). Thus, most recent studies
have examined REST in the context of its function in the regulation of neuronal
differentiation genes. Our recent studies are the first to attribute a novel role for REST
in the control of cell proliferation and cell cycle exit (73). We observed that ectopic
human REST transgene expression in NSC-Ms facilitated sustained proliferation, even
under differentiation conditions (3). Conversely, REST knockdown in NSC-M cells
caused a decline in cell numbers concomitant with a decrease in cell proliferation (73).
Together, our studies suggest that REST may function as a molecular switch that
coordinates cessation of cell proliferation with onset of neuronal differentiation (73).
The underlying molecular mechanism(s) of REST regulating proliferation is the major
goal of the current thesis project.
REST negatively regulates cell cycle exit
Consistent with a potential role for REST in the regulation of cell proliferation, it
is expressed only in the G1 phase of the cell cycle (24). Cell cycle exit is one of the
fundamental steps that must occur for cells to cease proliferating and begin expressing
terminal differentiation markers required for a neuronal phenotype. Transition through
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the cell cycle is governed by the activity of the cyclin/CDK complexes (40). These
complexes promote phosphorylation of RB protein, inactivating it, and allowing
progression through the cell cycle (40). The activity of CDK/cyclin complexes in turn is
regulated by the CDKIs (40). Given the importance of CDKIs in cerebellar development,
we examined if the expression of one or more of these CDKIs were subject to negative
regulation by REST. In the current study, we have identified the CDKI, p16Ink4a, as a
downstream target of the REST pathway and suggest that REST-dependent control of
cell proliferation may be achieved by repression of p16Ink4a expression.
p16Ink4a is a negative regulator of cell cycle progression
Work from several laboratories has linked p16Ink4a to the regulation of cell
proliferation in various progenitors and its dysregulated expression to oncogenesis (40,
55, 56, 68). p16Ink4a expression is relatively low in proliferating neural progenitor cells
with ubiquitous expression occurring only later in life when cells are terminally
differentiated (52-54, 58). Its activation leads to growth arrest, senescence and apoptosis
(52-54). In neural progenitors, its premature expression causes a significant decline in
proliferation and reduces self-renewal of NSCs in culture (41-43). Interestingly, p16Ink4a
is necessary for cell cycle exit, but its expression alone is insufficient to induce neuronal
differentiation (58). Other INK4a proteins, such as p15Ink4b, are required to induce
neuronal differentiation (58). The p16Ink4a gene, located on human chromosome 9p21, is
frequently deleted in many cancers including melanoma, glioblastoma, leukemia, and
medulloblastoma, suggesting that it functions as a tumor suppressor (40, 55, 56).
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REST and p16Ink4a are negatively correlated in vivo and in vitro during
differentiation of neural progenitor cells
In the current study, we have established a reciprocal pattern of expression
between REST and p16Ink4a in the developing postnatal cerebellum of mice. REST
expression was detected almost exclusively in the proliferating progenitors of the EGL
of P7 cerebella, a developmental stage at which maximal proliferation of progenitors is
observed. REST levels decline as cells exit the cell cycle and initiate their migration
down the ML to the IGL, where they become terminally differentiated neurons. Our
findings are consistent with that by Ravanpay and colleagues, who also showed REST
expression in the proliferating cells of the EGL (57). In contrast, p16Ink4a was not found
in the proliferating cells of the EGL, but showed significant expression in the postmitotic and terminally differentiated neurons of the IGL. These observations are similar
to findings by the Roussel group where they show p16Ink4a to be expressed post-natally
in neurons (58). In older P12 mice, the cerebellar EGL is largely depleted of progenitors
with a vast majority of these cells having terminally differentiated into neurons of the
IGL. Consistent with diminished proliferation rates of CPCs in the murine P12 cerebella,
REST expression is detected only at very low levels in these cells. These findings are
again similar to that described by the Olson group (57). The significant increase in
p16Ink4a levels in most post-mitotic cells of the P12 murine cerebellum is in line with its
function as a CDKI.
These observations were recapitulated in vitro during neuronal differentiation of
NSC-M neural progenitors. REST has been shown to be expressed in neural progenitors
and be downregulated in neurons (13, 14, 19) while p16Ink4a has been shown to be
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expressed only in differentiated neurons (58). Our observations showed that
downregulation of REST mRNA and protein levels coincided with upregulation of
p16Ink4a mRNA and protein levels during neuronal differentiation of NSC-M cells,
consistent with previous studies. Interestingly, as seen by IFA, NSC-MR cells show
REST to be localized in the cytoplasm as well as in the nucleus. This potentially
suggests a role for REST in regulating itself through a negative feedback loop when its
levels exceed a certain threshold. This feedback loop may cause REST to be degraded
and therefore be expressed in the cytoplasm and may be a subject worth investigating.
Collectively, these findings indicate a reciprocal relationship between REST and p16Ink4a.
Furthermore, constitutive expression of human REST transgene in NSC-MR cells
blocked upregulation of p16Ink4a mRNA and protein levels, even under neuronal
differentiation conditions. These findings suggest a potential role of REST expression in
contributing to uncontrolled proliferation of NSC-MR cells by regulating p16Ink4a
expression. We further validated our findings by protein and sub cellular localization
through IFA in NSC-M and NSC-MR cells and together, all of these findings
recapitulated the reciprocal relationship between REST and p16Ink4a. The mechanism by
which this relationship occurs is discussed below and is a sub aim of the current thesis
project.
REST indirectly regulates p16Ink4a expression
REST is a transcriptional repressor that regulates expression of many neuronspecific genes by binding a motif called the RE1 element present in the regulatory
regions of its target genes. Since our observations suggest that these changes in p16Ink4a
expression may be in response to differences in REST levels or activity during neuronal
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differentiation, we first asked if REST had the potential to regulate p16Ink4a transcription
(13, 20, 21).

We conducted a computational analysis of the p16Ink4a locus for a

consensus RE1 binding site, however, this search did not reveal the REST binding motif,
suggesting that the effect of REST on p16Ink4a may be indirect.
Bmi-1 transcriptionally regulates p16Ink4a expression
Previous studies have linked Bmi-1, a polycomb group gene and epigenetic
regulator of gene expression (60, 61) to the transcriptional regulation of p16Ink4a in CPCs.
Bmi-1 mediated control of the Ink4a locus that encodes p16Ink4a is important for the
maintenance of proliferation and self-renewal potential in these progenitor cells as
demonstrated by the following studies (59, 60, 62). In Bmi-1 null (Bmi-1-/-) mice,
p16Ink4a is precociously upregulated in NSCs and progenitor cells causing a reduction in
self-renewal leading to a morphologically smaller cerebella, including significantly
thinner granular and molecular cells layers (43). Loss of INK4a in Bmi-1-/- mice
prevents neurogenesis in vivo and partially rescued the defect in self-renewal, suggesting
that repression of p16Ink4a is necessary for stem cell self-renewal in the presence of Bmi1 (42). These findings led us to hypothesize that REST-dependent transcriptional
regulation of p16Ink4a expression maybe mediated by Bmi-1.
REST maintains Bmi-1 expression by repressing miR-203
However, the absence of a RE1 site in the upstream or downstream regulatory
region of Bmi-1 gene makes it unlikely to be a direct target of REST. Interestingly,
recent reports in the literature identified Bmi-1 as a target of microRNAs (miRs),
specifically of miR-15a and miR-16, in ovarian cancer (48) and miR-203 in pancreatic
cells (49). MicroRNAs are important for the control of neurogenesis and neural cell fate
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specification during brain development (64). Some of the most widely expressed miRs in
the nervous system, including miR-124 and miR-9 (22, 31-33), are regulated by REST.
This led us to suspect that REST-dependent maintenance of Bmi-1 expression may be
through a miR known to negatively regulate Bmi-1. Our subsequent studies led us to
identify miR-203 as a direct REST target as measured by qRT-PCR analyses and ChIP
assays. REST showed significant binding to the miR-203 regulatory region relative to
IgG controls in NSC-M and NSC-MR cells. Our observations are consistent with other
studies that have demonstrated that miR-203 interacting with REST in the mouse NSC
line, NS5 (50). Additionally, miR-203 has a stemness-inhibiting and pro-differentiation
function in skin progenitor cells (65) and was previously shown to directly inhibit Bmi-1
expression in human pancreatic cancer cells (49). Finally, although we have focused on
miR-203 in our studies, miR-183 expression also changed in a REST-dependent manner.
However, the lack of a RE1 motif suggests that its expression may be controlled by other
intermediate REST target genes.
Previous work using mouse ESCs also showed that induction of neuronal
differentiation was associated with a decrease in Bmi-1 levels and a reciprocal increase
in miR-203 expression (49). We observed a similar decline in REST and Bmi-1, and an
increase in miR-203 expression during neuronal differentiation of neural progenitors in
vitro. This also corroborates other results from previous studies where Bmi-1 expression
is reduced (66) and miR-203 expression increases as cells differentiate (49).
In contrast, constitutive-REST expressing NSC-MR cells blocked the
upregulation of miR-203 expression during neuronal differentiation and maintained Bmi1 expression. This data coincided with previous work that shows NSC-MR cells fail to
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differentiate and have sustained proliferation (3). We further validated our findings by
protein and sub cellular localization through IFA in NSC-M and NSC-MR cells. This
provides the first connection between REST and Bmi-1 through miR-203 and potentially
with self-renewal of CPCs (50). Reporter assays will provide further in vitro
confirmation of these relationships.
In vivo, we established a concomitant pattern of expression between REST and
Bmi-1 in the developing postnatal cerebellum of mice. REST and Bmi-1 expression was
detected almost solely in the proliferating progenitors of the EGL of P7 cerebella. REST
and Bmi-1 levels decline as cells exit the cell cycle and initiate their migration down the
ML to the IGL, where they become terminally differentiated neurons. In older P12 mice,
REST and Bmi-1 expression are detected only at very low levels, consistent with
diminished proliferation potential of CPCs in the murine P12 cerebella.
Our in vivo and in vitro studies described provide the basis for further
investigations in the relationship between REST, miR-203, Bmi-1, and p16Ink4a in the
regulation of cell proliferation and self-renewal of neural progenitors in mice with
conditional REST knockout in the cerebellum. In vitro, elevated expression of either
REST or Bmi-1 causes sustained proliferation of immortalized neural progenitors (3, 46).
Hyper-proliferation is a hallmark of cancers and consistent with this, knockdown of Bmi1 or REST in human MB cell lines suppresses their tumorigenic potential in mouse
orthotopic models (35, 67). Elevated levels of REST (unpublished data) or lower levels
of p16Ink4a (68) expression in tumor tissue of patients with MB have been independently
associated with poor prognosis. Maintenance of REST and Bmi-1 leads to inhibition of
miR-203 and p16Ink4a and may contribute to uncontrolled proliferation of progenitor cells
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and potentially tumorigenic cells. It would be interesting to assess the involvement of
miR-203 and p16Ink4a in the process of tumorigenesis in mouse models of the disease (3).
Attenuation of REST signaling may have therapeutic implications and could be
potentially achieved by upregulating miR-203 in these tumors. Additional studies are
needed to provide a better understanding of how deregulation of this pathway may
contribute to tumor formation of MB.

55

Chapter 5
Conclusions and Future Direction
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Conclusions
We have demonstrated that:
1. REST and p16Ink4a are reciprocally expressed in the developing post-natal
cerebellum of mice.
We showed that in P7 mice, where maximal proliferation of CPCs is observed,
REST is expressed in the proliferating cells of the expanding EGL but not in the
differentiated neurons of the cerebellum. Conversely, p16Ink4a was not found in the
proliferating cells of the EGL and was only expressed in the post-mitotic and
terminally differentiated neurons of the IGL. In P12 mice where cells are
predominantly post-mitotic, REST levels are substantially reduced.

In contrast,

p16Ink4a was detected in these post-mitotic and terminally differentiated cells of P12
mice.
2. REST and p16Ink4a are reciprocally correlated in vitro during neuronal
differentiation of progenitor cells
We cultured NSC-M cells under proliferation or differentiation conditions and we
observed downregulation of REST mRNA and protein levels coincident with
upregulation of p16Ink4a mRNA and protein levels upon onset of neuronal
differentiation.
3. Constitutive REST expression in progenitors (NSC-MR cells) blocks
upregulation of p16Ink4a.
We observed that maintenance of REST expression in NSC-MR cells enforced
suppression of p16Ink4a mRNA and protein expression in NSC-MR cells both under
proliferation and differentiation conditions.
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4. REST-dependent regulation of p16Ink4a appears to be indirect since p16Ink4a
lacks a REST binding site.
5. The polycomb protein Bmi-1, a known repressor of p16Ink4a transcription is
positively correlated with REST in proliferating progenitors and differentiated
neurons in the murine cerebellum.
In P7 mice, REST and Bmi-1 are both expressed in the proliferating progenitor cells
of the expanding EGL but not in the differentiated neurons of the IGL. In P12 mice,
where most progenitors are post-mitotic, REST and Bmi-1 levels are substantially
reduced or absent.
6. In vitro, the expression of Bmi-1 is maintained in proliferating REST-expressing
CPCs and NSC-M cells but not in differentiated neurons where REST was
absent as well.
We cultured NSC-M cells under proliferation or differentiation conditions and
observed downregulation of REST mRNA and protein levels during neuronal
differentiation, which coincided with a decline in Bmi-1 mRNA and protein level.
Conversely, NSC-MR cells that express REST in a constitutive manner maintained
Bmi-1 expression under proliferation and differentiation conditions.
7.

MiR-203, a negative regulator of Bmi-1 expression shows a pattern of
expression that is reciprocal to the expression of REST and Bmi-1 in
proliferating and differentiating progenitors.
We cultured NSC-M cells under proliferation or differentiation conditions and
observed downregulation of REST mRNA and protein levels during neuronal
differentiation, which coincided with an increase in miR-203 expression.
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8. Constitutive REST expression blocked upregulation of miR-203 in NSC-MR
cells. We observed that constitutive REST expression in NSC-MR cells prevented
upregulation of miR-203 expression.
9. REST binds to the downstream regulatory region of miR-203 in NSC-M and
NSC-MR cells.
We showed that REST significantly binds to the miR-203 regulatory region relative
to control immunoglobulin in NSC-M and NSC-MR cells.
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Future Directions

1. To investigate the correlation between REST, miR-203, Bmi-1 and p16Ink4a in
primary progenitors
In further validate our findings in NSC-M progenitors, our next step would be to see
how REST and p16Ink4a are correlated in primary progenitors grown under either
proliferation or differentiation conditions. miR-203 and Bmi-1 expression will also
be assessed in these cells. We believe that REST and Bmi-1 mRNA and protein levels
would decline under neuronal differentiation while miR-203 and p16Ink4a would be
upregulated, confirming the reciprocal correlation seen in NSC-M cells.
2. To investigate miR-203, Bmi-1 and p16Ink4a expression n mice with conditional
knockdown of REST expression in CPCs.
To further investigate the effect of REST knockdown on p16Ink4a expression and cell
proliferation, mice lacking REST expression in the cerebellar EGL are being
generated.

The expression of Bmi-1 and p16Ink4a will be examined by

immunofluorescence assay using cerebella harvested from animals at various times
after birth. The expression of these molecules as well as miR-203 will be studied by
qRT-PCR/Western blotting in vitro in dissociated primary progenitors. We anticipate
that by inhibiting REST, Bmi-1 would also be downregulated while p16Ink4a would
be upregulated.
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3.

To examine the effect of miR-203 overexpression on Bmi-1 and p16Ink4a
expression.
In our current study, we showed that REST overexpression causes a downregulation
of miR-203 levels. Therefore we propose that countering REST expression by
overexpressing miR-203 might abrogate proliferation of these cells through
downregulation of Bmi-1 expression and upregulation of p16Ink4a. NSC-M cells,
NSC-MR cells, and primary progenitors will be transfected with miR-203 or control
non-specific oligonucleotides. First changes in cell numbers will be plotted. Next,
cell extracts will be subjected to Western blotting and immunofluorescence assay.
We expect that constitutive miR-203 expression will cause a decline in proliferation
and cell numbers through repression of Bmi-1 expression and consequent
upregulation of p16Ink4a levels.

4. To interrogate if miR-203 is a direct target of REST using reporter assays.
We showed in the current study that REST binds the RE1 element in the miR-203
regulatory region, suggesting that it may be a direct REST target. We will use clone
the RE1 element from the miR-203 locus into reporter constructs and luciferase
assays will be performed to confirm REST-dependent changes in reporter gene
expression in NSC-M and NSC-MR cells. The RE1 site will also be mutated to
abolish REST binding and changes in reporter gene expression will be evaluated in
NSC-M and NSC-MR cells.

We expect miR-203 luciferase activity to be

significantly lower in NSC-MR cells compared to NSC-M cells. Further, we expect
miR-203 luciferase activity to be upregulated when the RE1 site is mutated.
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5. To study the relationship between REST and p16Ink4a in human
medulloblastomas known to express REST at elevated levels.
A major goal of our laboratory is to investigate the oncogenic function of REST in
medulloblastoma, which are undifferentiated, hyperproliferative cancer arising from
the cerebellar granular progenitors. Our previous and ongoing studies have
demonstrated elevated REST expression in human medulloblastoma samples and
shown this to be associated with poor prognostic significance for patients with the
disease (38, 35, Taylor et al., in preparation). We also showed REST to contribute to
blockade of neuronal differentiation and to be important for tumor progression and
maintenance using mouse orthotopic models (38). Our recent studies have implicated
elevated REST expression in neural progenitors to the deregulation of cell
proliferation (73). Based on the findings of this thesis project, we propose that
elevated REST expression in medulloblastoma may repress miR-203 expression and
lead to failure in p16Ink4a. We will use genetic and biochemical approaches in vitro
and in vivo to test this hypothesis.
6. To evaluate the therapeutic potential of constitutive miR-203 expression in
REST-expressing medulloblastoma in mouse orthotopic models.
If miR-203 expression is important for upregulation of p16Ink4a transcription and
inhibiting cell cycle progression, then its expression is also likely to abrogate the
tumorigenic potential of REST-expressing human medulloblastoma cells, a postulate
that will be tested in mouse orthotopic models.
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Chapter 6
Materials and Methods
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6.1

Cell Culture
The mouse multipotent C17.2 (NSC-M) cell line (3, 69) was derived from

neonatal mouse cerebellum and was cultured at 5% carbon dioxide, at 37°C in medium
containing Dulbecco’s modified Eagle’s medium, (DMEM), 10% fetal bovine serum
(FBS), 5% heat inactivated horse serum (HS), 2 mM l-glutamine, and 1%
antibiotic/antimycotic solution (PSF) (all from Invitrogen, Carlsbad, CA). For
proliferation conditions, cells were plated at a low confluency (30%), grown in
proliferation medium (DMEM, 10%FBS, 5% HS, 2mM l-glutamine, and 1%
antiobiotic/antimycotic solution) and collected after a day. NSC-M cells are known to
differentiate at high confluency, so for differentiation conditions, cells were plated at
50% confluency, allowed to grow in proliferation medium to 100% confluency and
collected after 5 days. NSC-M cells engineered to constitutively express REST (NSCMR) under a doxycycline regulable promoter (previously described in Su and
Gopalakrishnan, 2006 (3)) were cultured in both proliferation and differentiation
conditions as described above.
6.2

Total RNA Isolation
Total RNA was extracted from NSC-M and NSC-MR cells using Trizol reagent

(Invitrogen, Carlsbad, CA) and Chloroform (Sigma-Aldrich, St. Louis, MO) according
to the Trizol manufacturer’s guidelines (Invitrogen, Carlsbad, CA). Briefly, media was
removed and 1ml of Trizol reagent was used to disrupt the cell pellet. 0.2ml of
chloroform was added to lyse the cells followed by centrifugation (Hettich Rotina 35R,
Hettich Zentrifugen, Hettich, Germany) at 12,000g for 15 minutes (min) at 4°C. The
aqueous upper phase was collected in a minicentrifuge tube, precipitated with 0.5ml of
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Isopropanal, and centrifuged at 12,000g for 10 min at 4°C. The pellet was then washed
with 1ml of 75% ethanol, centrifuged at 7,500g for 5 min at 4°C, dried and resuspended
in RNAse-free water.

RNA concentration was determined by spectrophotometric

analysis (Nanodrop 1000 spectrophotometer, Thermo Scientific, Rockford, IL) and
stored at -80°C. All experiments were performed in triplicate.
6.3

Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR)
Total RNA was isolated from NSC-M cells and NSC-MR cells grown under

proliferation or differentiation conditions as described in section 6.1. Complementary
DNA (cDNA) was synthesized from 1µg of total RNA from NSC-M and NSC-MR using
the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). Briefly, 4µl of 4x
iScript Reaction Mix, 1µl of iScript Reverse Transcriptase and 1µg of Total RNA were
diluted in water according to the manufacturer’s guidelines. Quantitative PCR (qPCR)
reactions were done using iQ Syber Green Supermix (Bio-Rad Laboratories, Hercules,
CA) and primers specific to mouse REST, p16Ink4a, Bmi-1, and Synapsin (Integrated
DNA Technologies, Coralville, IA). Gene expression was normalized to mouse 18S
RNA levels. Relative mRNA measurements were done using the Comparative ∆∆ct
method as previously described (70). All experiments were performed in triplicate.
Primer sequences are as follows:
Table 1: Forward and Reverse Primers for qRT-PCR
Forward Primer 5’-3’

Reverse Primer 5’-3’

Mouse REST

GTGCGAACTCACACAGGAGAACG

GCTTCTCACCTGAATGAGTCCGCATA

Mouse p16Ink4a

GAGCAGCATGGAGTCCGCTGC

GTTGCCCATCATCATCACCTG

Mouse Bmi-1

CTGCCAATGGCTCCATGAA

TTCCGATCCAATCTGCTCTG

Mouse Synapsin

CTCATTCCTCAGTATTCCCTT

GAAATCACCCTTTAGATGTAC

Mouse 18S

GAACTCACGGAGGATGAGGTG

GTTGGCCAGAACCTGGCTGTA
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6.4

Western Blotting
Pellets were collected from NSC-M cells and NSC-MR cells cultivated under

proliferating/differentiating conditions as described in section 6.1. Pellets were
resuspended in 100µl western blot (WB) lysis buffer (50mM potassium chloride (KCL),
10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.5), 5mM
Tris-Chloride (Tris-Cl) (pH 7.5), 10% glycerol, 2mM ethylenediaminetetraacetic acid
(EDTA), 1mM DTT, 1% Triton X-100, 0.4% octylphenoxypolyethoxyethanol (Igepal),
1% protease inhibitors (Halt, Thermo Scientific, Rockford, IL) diluted in water)
followed by sonication (Misonix Sonicator 3000, Misonix Incorporated, Farmingdale,
NY). Samples were then spun at 15,000g for 10 min at 4°C to pellet debris and the
supernatant was collected. Protein concentration was determined using a 1:5 dilution in
water of Commassie blue reagent (Bio-Rad Protein Assay Dye-Reagent concentrate,
Bio-Rad Laboratories, Hercules, CA). 995µl of 1:5 diluted Commassie blue reagent was
mixed with 5µl of Protein and analyzed by spectrophotometric analysis at 600 nm
(Genesys 10-S, Thermo Electron Corporation, Waltham, MA).

Samples were

electrophoresed by denaturing polyacrylamide gel electrophoresis (PAGE) using sodium
dodecyl sulfate (SDS). Electrophoresed proteins were transferred to a Hybond-P
membrane (GE Healthcare, Little Chalfont, UK) in Transfer Buffer (3.03g Tris, 14.4g
Glycine, 100ml Methanol, and 900ml of water). Membranes were blocked with 5%
milk in Phosphatase Buffered Saline (PBS) with 0.1% Tween and incubated with
primary antibodies as followed: REST (1:1000, Millipore, Waltham, MA), Bmi-1
(1:1000, Millipore, Waltham, MA), Tuj1 (1:1000, Covance, Denver, PA), Actin
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(1:20,000, Cell Signaling, Danvers, MA), p16ink4a (1:1000, Santa Cruz Biotechnology,
Santa Cruz, CA). Blots were incubated with peroxidase conjugated secondary antibodies
against rabbit or mouse immunoglobulins (IgGs) and the immunocomplexes were
visualized using Super Signal West Dura Enhanced Chemiluminescence (ECL) reagent
(Thermo Scientific Pierce, Rockford, IL) and a Kodak film developer (Eastman Kodak).
All experiments were performed in triplicate.
6.5

Chromatin Immunoprecipitation (ChIP) Assay
First, we prepared two times cross linking and homogenization mix (XHM) was

prepared using 100mM Hepes (pH 8.0), 280 mM Sodium Chloride (NaCl), 2mM EDTA
(pH 8.0), 0.8% Igepal CA-630, and 0.4% Triton X-100 diluted in water to final volume.
Next we prepared cross-linking buffer (XLB) using XHM diluted 1:2 and protease
inhibitors diluted in water to final volume. Cells were divided into aliquots of 1 million
cells and pelleted by centrifugation at 5,000 rpm for 1 min at 4°C and cross-linked using
XLB mixed with 1% formaldehyde. Samples were mixed by inverting 10 times and
incubated with rocking for 10 min at room temperature (RT). The cross-linking was
neutralized by adding 1/10 total volume of 1.4 M Glycine and rocking for 5 min at RT.
The nuclei were pelleted by centrifugation at 14,000 rpm for 1 minute and then
resuspended in 1 ml of homogenization buffer (XHM diluted 1:2 and protease inhibitors
diluted in water to final volume). The nuclei were pelleted by centrifugation at 14,000
rpm for 1 minute and then washed with 1 ml of Nuclear Wash Buffer (1:10 dilution of
10X Nuclear Wash Buffer (200 mM Tris-hydochloride (Tris-HCL) (pH 8.0), 10mM
EDTA (pH 8.0), and 1.5M NaCl) and protease inhibitors diluted in water to final
volume) twice and centrifuged at 14,000 rpm for 1 minute.
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Cross-linked NSC-M or NSC-MR cells were resuspended in sonication buffer
(50 mM Tris-HCL (pH 8.0), 10mM EDTA (pH 8.0), 1% SDS, and protease inhibitors)
and sonicated. The samples were centrifuged twice for 1 minute each at 14,000 rpm to
remove debris. For each set, 10% was saved as input DNA and the remaining 90% was
diluted 10-fold with ChIP dilution buffer (16.7 mM Tris-HCL (pH 8.0), 167 mM NaCl,
1.2 mM EDTA (pH 8.0), 1.1% Triton X-100, and protease inhibitors diluted in water to
the final volume) and pre-cleared by incubation with Protein G magnetic beads for 2 hrs
at 4°C with shaking. The samples were then centrifuged at 3,000 rpm for 1 minute. The
pre-cleared supernatant was incubated with 5µg anti-REST antibody or 5µg control IgG
for 12 hrs at 4°C with shaking followed by addition of Protein G magnetic beads for 2
hrs at 4°C with shaking. Beads were collected by centrifugation at 1,000 rpm for 1
minute and then washed once with the following buffers: Wash buffer I (10mM Tris-Cl
(pH 8.0), 150mM NaCl, 2mM EDTA (pH 8.0), 0.1% SDS, 1% Triton X-100 diluted in
water to the final volume); Wash buffer II (20mM Tris-Cl (pH 8.0), 500mM NaCl, 2mM
EDTA (pH 8.0), 0.1% SDS, 1% Triton X-100 diluted in water diluted in water to the
final volume); Wash buffer III (10mM Tris-Cl (pH 8.0), 0.25 M Lithium Chloride (LiCl),
1mM EDTA (pH 8.0), 1% Igepal CA630, 1% deoxycholate diluted in water to the final
volume); Wash buffer IV (Tris EDTA (TE) (pH 8.0). After washing, the beads were then
eluted with elution buffer (2%SDS, 0.2M Sodium Bicarbonate (NaHCO3) diluted in
water to the final volume) and vortexed at RT for 10 min. The beads were pelleted with
a magnetic rack and supernatants moved to a new tube and mixed with 1 volume of 2X
dilution buffer (20mM Tris-HCL (pH 8.0), 2mM EDTA (pH 8.0) diluted in water.
Elution buffer (Diluted 1:2) was added to inputs. Cross-linking was reversed by adding
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5M NaCl to a final concentration of 0.3M to the elutants and inputs and incubated at
65°C for 6 hours. The DNA was purified with a QiaQuick PCR Purification kit (Qiagen,
Valencia, CA). Bound DNA was quantified using SYBR-Green qPCR analyses as
previously described (Das et al., 2010) and analyzed with IQ5 Real-Time PCR Detection
System (Bio-Rad Laboratories, Hercules, CA). Calculations following normalization to
input values were done as described previously (71). Briefly, the highest value was set to
1 and control IgG values were subtracted from the target (REST) value. All experiments
were performed in triplicate. Primers used as follows:
Table 2: ChIP Forward and Reverse Primers.

Mouse miR-203 (10kb)

6.6

Forward Primer 5’-3’

Reverse Primers 5’-3’

GAAGGCAGCAGACACATGGCT

GTCTGTGGTCGTGTAGCCTTA

Immunofluorescence assay (IFA)
NSC-M and NSC-MR cells were seeded in Lab-Tek II Chamber Slides (Thermo

Fisher Scientific, Rochester, NY) under proliferation or differentiation conditions as
described in section 6.1. Cells were fixed with 2% buffered paraformaldehyde, blocked
(5% dry milk, 0.2% Triton-X 100, 1% Goat serum in PBS) and incubated with rabbit
anti-REST (1:100, Millipore, Waltham, MA), mouse anti-Bmi-1 (1:100,

Millipore,

Waltham, MA), or mouse anti-p16 (1:150, Santa Cruz Biotechnology, Santa Cruz, CA)
in PBS for 90 min. After washing with PBS three times for three min, the cells were
incubated with Cy3-labeled goat anti-rabbit IgG (Amersham, Pittsburgh, PA) or Alexa
Fluor 488 goat anti-mouse IgG (Invitrogen, Carlsbad, CA) for one hour. They were then
covered with Slowfade Gold_antifade (Invitrogen, Carlsbad, CA) containing 1 µg/ml
DAPI and sealed. Images were visualized using a Nikon Fluorescence microscope
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(Nikon Inc., Melville, NY) and analyzed using Metamorph software (Molecular Devices,
Downington, PA).
6.7

Immunohistochemistry (IHC)
Mouse cerebellar sections sample slides were placed on a hot plate for 20 min

and then deparaffinized and hydrated. Briefly, slides were immersed in xylene for 4 min
followed by a second treatment for 3 min. Then, the slides were immersed in 100%
ethanol twice for 2 min, 95% ethanol twice for 1 min, 80% ethanol for 1 min followed
by PBS twice for 2 min. The slides were then placed in citrate buffer (0.1M Sodium
Citrate) and steamed for 25 min for antigen retrieval. Tissues were allowed to cool for
30 min, and then blocked (5% dry milk, 1% goat serum in PBS) for 20 min and
incubated with rabbit anti-REST (1:50), mouse anti-p16 (1:150), or mouse anti-Bmi-1
(1:100) in blocking solution at 4ْ°C over night in a humid chamber. Slides were washed
in PBS and incubated with Cy3-or A488 conjugated secondary antibodies (1:800 in PBS,
Invitrogen, Carlsbad, CA) and then covered with Hoescht 33342 (1:10,000 in PBS).
Images were visualized using a Nikon Fluorescence microscope and analyzed using
Metamorph software.
6.8

Taqman® assay to measure MicroRNA (miR) expression
Total RNA was isolated from cells using TRIZOL reagent as described in section

6.2.

Endogenous mature microRNA (miR) levels were quantified using TaqMan®

MicroRNA assay (Applied Biosystems, Carlsbad, CA). First, total RNA was reverse
transcribed using the TaqMan® MicroRNA Reverse Transcription Kit (Applied
Biosystems, Carlsbad, CA). Briefly, miR specific cDNA was prepared using 100mM
deoxynucleotide triphosphate (dNTPs), 50 U/µL MultiScribe Reverse Transcriptase,
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10X Reverse Transcription buffer, 20 U/µL RNase inhibitor, miR primers (U6, miR-203,
miR-183, miR-221, miR-16, miR-15a, and miR-194, Applied Biosystems, Carlsbad, CA)
5µg of total RNA and nuclease-free water and amplified using a thermal cycler as
follows: 30 min at 16°C, 30 min at 42°C, 5 min at 85°C, and 4°C indefinitely. This was
followed by qPCR using TaqMan® Universal PCR Master Mix, No AmpErase® Uracil
N-glycosylase (UNG) (Applied Biosystems, Carlsbad, CA). Briefly, cDNA (diluted 1:10
in water) was mixed with 20X TaqMan MicroRNA Assay, TaqMan 2X Universal PCR
Master Mix, No AmpErase UNG, and nuclease-free water. This was then run on a 384
qRT machine (Applied Biosystems, Carlsbad, CA) for 10 min at 95°C, followed by 40
cycles of 15 seconds at 95°C and 1 minute at 60°C. Relative abundance of miR fold
difference relative to U6 small nuclear RNA (RNU6B) expression was done using the
comparative ∆∆ct method as described earlier (72). All experiments were performed in
triplicate.
6.9

Animals

All animal experiments were approved by the Institutional Animal Care and Use
Committee at The University of Texas M.D. Anderson Cancer Center. Mice were
purchased from Jackson Laboratories (Strain C57BL6) and mated. The brains of the
resulting pups were harvested various days after birth and fixed in paraformaldehyde and
paraffin embedded. Tissue sections were analyzed by IFA assays as described in section
6.7.
6.10

Statistical Analysis:
We used STATISTICA 6.0, Anova one-way software to analyze qRT-PCR and

ChIP data. For qRT-PCR, the treated values (differentiation values) minus the untreated
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values (proliferation values) were used in a one-way analysis of variance, with post hoc
analysis using the Fisher least significant difference (LSD) to determine significant
differences. P < 0.05 was considered statistically significant. For ChIP, the sample
values (REST) minus the control values (IgG) were used in one-way analysis of variance,
with post hoc analysis using the Fisher LSD to determine significant differences. P <
0.05 was considered statistically significant.
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Supplemental Figures

REST expressing cells blocked p16Ink4a upregulation.
To examine the relationship between REST and p16Ink4a during neuronal
differentiation of neural progenitors in vitro, NSC-M cells were cultured under
proliferation or differentiation conditions. Total RNA was collected and mRNA levels
were quantified by qRT-PCR analyses. Relative REST and p16Ink4a mRNA levels were
determined following normalization to 18S mRNA levels, and then normalization to
proliferation values. Downregulation of REST gene expression during neuronal
differentiation significantly correlated with upregulation of p16Ink4a gene expression (Fig.
16). The terminal differentiation marker Synapsin1 (Syn1) was used as a positive control
since it is an established REST target gene.
Conversely, NSC-MR cells cultured under these conditions maintained REST
expression and failed to upregulate p16Ink4a mRNA levels, even when cultured under
neuronal differentiation conditions (Fig. 16). Together these findings suggest that
maintenance of REST expression and a failure to upregulate p16Ink4a expression may
contribute to uncontrolled proliferation of NSC-MR cells.
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Figure 16: Maintenance of REST expression blocks p16Ink4a upregulation. NSC-M
(top panel) and NSC-MR (bottom panel) cells were grown under proliferation or
differentiation conditions. Total RNA was prepared, converted to cDNA, and
analyzed by SYBR Green qRT-PCR to measure changes in gene expression of REST,
p16Ink4a (p16), and Synapsin1 (Syn1). Experiments were done in triplicate, and error
bars are indicated. Statistical analysis was done using Statistica 6.0 (*-p<0.05, **p<0.01).
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REST-dependent Changes in miR-203 expression.
NSC-M and NSC-MR cells were cultured under proliferation and differentiation
conditions and examined by TaqMan MicroRNA assay followed by qRT-PCR analyses.
Gene expression was determined following normalization to U6 small nuclear RNA
(RNU6B) mRNA levels. As highlighted in Fig. 17, miR-203 expression was significantly
downregulated in REST overexpressing NSC-MR cells relative to NSC-M cells.

Figure 17: MiR-203 and miR-183 fluctuate in a REST dependent manner. NSC-M
and NSC-MR cells were grown under proliferation conditions. Total RNA was
prepared and miR expression was quantified by TaqMan MicroRNA assay followed
by qRT-PCR analyses to measure changes in miR expression. Mir-203 expression is
significantly downregulated in NSC-MR cells relative to NSC-M cells. Experiments
were done in triplicate, and error bars are indicated. Statistical analysis was done
using Statistica 6.0 (*p<0.05, **p<0.01).
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Constitutive REST expression blocked miR-203 upregulation and maintained Bmi1 expression in differentiated neural progenitors.
To better understand the relationship between REST, miR-203, and Bmi-1
expression we cultured NSC-M cells under either proliferation or differentiation
conditions. Total RNA was collected, converted to cDNA and 18s, Bmi-1, Syn1, and
REST gene expression quantified by SYBR Green qRT-PCR. For miR-203
measurements, total RNA was collected and mRNA levels were assessed by TaqMan
MicroRNA assay followed by qRT-PCR analyses. REST gene expression (normalized to
18S expression, and then proliferation values) and miR-203 (normalized to RNU6B
expression, and then proliferation values) mRNA levels were found to be reciprocally
correlated in differentiating NSC-M cells (Fig. 18). This shows downregulation of REST
gene expression during neuronal differentiation caused a significant upregulation of
miR-203 gene expression (Fig. 18). The terminal differentiation marker Synapsin (Syn1),
a known REST target gene was upregulated under these conditions and was used as
positive control. Importantly, Bmi-1 mRNA levels were downregulated concomitant with
a decline in REST mRNA levels during neuronal differentiation (Fig. 18).
In contrast, maintenance of REST expression in NSC-MR cells blocked the
upregulation of miR-203 mRNA levels, even when cultured under differentiation
conditions (Fig. 19). This correlated with maintenance of Bmi-1 mRNA levels in these
cells (Fig. 19).
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A.

B.

Figure 18: REST gene expression and miR-203 mRNA levels were found to be
reciprocally correlated in differentiating NSC-M cells. NSC-M cells were grown
under proliferation or differentiation conditions. A.) Total RNA was prepared,
converted to cDNA and analyzed by SYBR Green qRT-PCR to measure changes in
gene expression of REST, Bmi-1, and Synapsin1 (Syn1). B.) Total RNA was prepared,
and mRNA levels assessed by Taqman MicroRNA assay followed by qRT-PCR
analyses to measure changes in gene expression of miR-203. Experiments were done
in triplicate, and error bars are indicated. Statistical analysis was done using Statistica
6.0 (*p<0.05, **p<0.01).
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Figure 19: Maintenance of REST expression blocks miR-203 upregulation and
maintains Bmi-1 expression. NSC-MR cells were grown under proliferation or
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed
by SYBR Green qRT-PCR to measure changes in gene expression of REST, Bmi-1,
and Synapsin1 (Syn1). For miR-203, total RNA was prepared, and mRNA levels
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure
changes in gene expression. Experiments were done in triplicate, and error bars are
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01).
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